BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26618405)

  • 1. Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.
    Gong SJ; Feng XJ; Song WH; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM
    Cancer Biol Ther; 2016; 17(2):151-62. PubMed ID: 26618405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.
    Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
    Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
    Qian Y; Wang B; Ma A; Zhang L; Xu G; Ding Q; Jing T; Wu L; Liu Y; Yang Z; Liu Y
    Sci Rep; 2016 Sep; 6():33039. PubMed ID: 27633997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
    Wang Q; Cheng ST; Chen J
    Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
    [No Abstract]   [Full Text] [Related]  

  • 8. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
    Li W; Li M; Liao D; Lu X; Gu X; Zhang Q; Zhang Z; Li H
    Oncotarget; 2016 Aug; 7(34):55110-55127. PubMed ID: 27391153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
    Liao B; Zhou H; Liang H; Li C
    Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
    Kim YR; Byun MR; Choi JW
    Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
    Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B.
    Wang X; Oishi N; Shimakami T; Yamashita T; Honda M; Murakami S; Kaneko S
    World J Gastroenterol; 2017 May; 23(18):3252-3261. PubMed ID: 28566884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.